- •Malignant
- •RISK FACTORS
- •Familial Atypical Mole Melanoma
- •Xeroderma Pigmentosum
- •Ultraviolet light
- •The ABCDEs of Melanoma Diagnosis
- •TYPES OF MELANOMA
- •NODULAR
- •SUPERFICIAL SPREADING
- •ACRAL LENTIGINOUS MELANOMA
- •SUBUNGAL MELANOMA
- •LENTIGO MALIGNA MELANOMA
- •AMELANOTIC MELANOMA
- •Mucosal melanoma
- •Ocular melanoma
- •Skin biopsy
- •Breslow Thickness:
- •Clark Level
- •Stage 0: (TisN0M0).
- •Stage I: Local disease - superficial
- •Stage II: Local disease - deep invasion.
- •Stage III: Regional disease
- •Stage IV: Metastatic disease
- •Prognostic factors
- •Sentinel lymph node biopsy
- •Sentinel lymph node mapping and biopsy
- •Adjuvant therapy
- •IPILIMUMAB
- •IFN - Side effects
- •Treatment Options for advanced Melanoma
- •Imunotherapy
- •Ipillimumab (Yervoy)
- •Anti PD1 therapy : Opdivo
- •Opdivo Monotherapy Phase 3 Trial: Improved OS Versus Dacarbazine in BRAF Wild-type,
- •59Updated Results From a Phase III Trial of Nivolumab Combined With Ipilimumab in
- •62Safety Summary
- •J.M. Michot et al. European Journal of Cancer 54 (2016)
- •Boutros et al. Nature Reviews Clinical Oncology Volume: 13, Pages:473–486 Year published:(2016)
- •Boutros et al. Nature Reviews Clinical Oncology 13, 473–486 (2016)
- •Webber JS , Safety profile of nivolumab in patients with advanced melanoma, Pooled
Malignant
Melanoma
Dr Olga Vornicova
Resident in Clinical oncology
Rambam Medical Center
RISK FACTORS
Fair skinned.
Hair color other than black.
Excessive sun exposure .
Melanoma in first-degree relative(s) .
Prior nonmelanoma skin cancer (basal cell and squamous cell carcinoma).
Presence of xeroderma pigmentosum or familial atypical mole melanoma syndrome.
Familial Atypical Mole Melanoma
Syndrome
Autosomal dominant
Neoplastic risk
"atypical melanocytic nevus“
25-40% with CDKN2A mutation
Xeroderma Pigmentosum
Rare Autosomal recessive disease
DNA repair enzyme defect
Photosensitivity
Photodamage
Cutaneous malignancies
Severe ophthalmological abnormalities
Early death from malignancy
Ultraviolet light
UVC (< 290 nm)
Completely absorbed by the atmosphere and is non-relevant for UV induced skin carcinogenesis.
UVB (290-390 nm)
Absorbed by ozone, but 5-10% of it reaches the earth surface.
The exposure to the high penetrating UVB radiation leads to DNA damage .
UVA (520-400 nm)
Genotoxicity seems to be induced by indirect mechanisms mediated by reactive oxygen radicals and associated with chronic sun damage changes.
The ABCDEs of Melanoma Diagnosis
Asymmetry |
|
One halflf off thet |
lesionl i isis shaped |
||||||
|
|
|
|
|
differentlyiff r tly thant thet othert r |
||||
|
|
|
Border |
|
|
|
|
|
The borderr r off thet |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
lesionl i isis irregular,irr l r, |
|
|
|
|
|
|
|
|
|
|
blurred,l rr , orr raggedr |
Colorl |
|
|
|
|
|
||||
|
|
Inconsistent pigmentation, with |
|||||||
|
|
|
I |
i t t i |
|
t |
ti , ith |
||
|
|
|
varyingr i shades off brownr |
and blackl |
|||||
|
|
Diameteri |
|
|
|
|
|
mm,, orr a 6> |
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
Evolutionl i |
|
|
|
|
|
progressiver r i |
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
change inin sizei |
||
Historyi t ry off change inin thet lesionl i |
|
|
|
|
|
|
|||
|
|
|
|
|
|
.Photos courtesy of the American Cancer Society
TYPES OF MELANOMA
NODULAR
–Commoner in males
–Trunk is a common site
–Poor prognosis
–Black/brown nodule
–Ulceration and bleeding are common